[New salazosulfapyridine derivatives. Progress in the treatment of chronic inflammatory diseases of the intestines?].
D000284:Administration, Oral; D000285:Administration, Rectal; D002908:Chronic Disease; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003424:Crohn Disease / Q000188:drug therapy; D004304:Dosage Forms; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D005944:Glucosamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D007410:Intestinal Diseases / Q000188:drug therapy*; D011350:Proctocolitis / Q000188:drug therapy; D012460:Sulfasalazine / Q000008:administration & dosage / Q000627:therapeutic use*
D004304:Dosage Forms; D004338:Drug Combinations; C028423:Salazopyrine; D012460:Sulfasalazine; D005944:Glucosamine
Les nouveaux dérivés de la salazosulfapyridine. Un progrès dans le traitement des maladies inflammatoires chroniques de l'intestin?